For example, research in hepatocellular carcinoma (43), in Chordoma (44), and in Colon Cancer (45) etc. Unlike in cancer patients, we observed decreased expression of MET in patients with AF by bioinformatic analysis, whereas MET is often overexpressed in cancer patients. This evidence concerns the gene MET and colonic neoplasm.